An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms.

Authors

K M Nylocks
V Michopoulos
A O Rothbaum
L Almli
C F Gillespie
Paul J. Marvar, George Washington UniversityFollow
+6 additional authors

Document Type

Journal Article

Publication Date

6-1-2015

Journal

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics

Volume

168B

Issue

4

Inclusive Pages

307-315

DOI

10.1002/ajmg.b.32313

Keywords

Angiotensins--metabolism; Peptidyl-Dipeptidase A--genetics; Polymorphism, Single Nucleotide--genetics; Stress Disorders, Post-Traumatic--drug therapy; Stress Disorders, Post-Traumatic--genetics

APA Citation

Nylocks, K., Michopoulos, V., Rothbaum, A., Almli, L., Gillespie, C., Marvar, P. J., & +6 additional authors (2015). An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms.. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 168B (4). http://dx.doi.org/10.1002/ajmg.b.32313

Peer Reviewed

1